Entrada Therapeutics, Inc. · NASDAQ:TRDA

T. Rowe Price Associates Inc reported a 6.80% stake in Entrada Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

T. Rowe Price Associates Inc reported a 6.80% stake in Entrada Therapeutics, Inc., 2,567,478 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
6.80%
Shares
2,567,478
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.6.80%2,567,478

Source

View original at SEC

Related